Cyclo Therapeutics Inc - Ordinary Shares - Class A

-0.03 (-2.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)26.45M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.14 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$1.51
50-Day MA$1.54
200-Day MA$1.43
See more pivots

Cyclo Therapeutics Inc - Ordinary Shares - Class A Stock, NASDAQ:CYTH

6714 NW 16th Street, Suite B, Gainesville, Florida 32653
United States of America
Phone: +1.386.418.8060
Number of Employees: 9


Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.